Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Expands Partnerships With Universities As Part Of MDEpiNet Program

This article was originally published in The Gray Sheet

Executive Summary

Yale had teamed up with Medtronic in one new FDA-funded project to improve post-market surveillance and use of registries. Duke University and the University of Washington have also received grants.

You may also be interested in...



Regulatory Briefs: Pre-Submission Program Final Guidance; FDA Meetings; HHS Health IT Nominations

FDA issues final guidance on its pre-submission program. The agency announced upcoming Gastroenterology and Urology Devices advisory panel meetings and a workshop for its Medical Device Epidemiology Network. More regulatory news.

FDA To Issue Final Device Post-Market Surveillance Plan In February

The device center plans to publish the final version of its national device post-market surveillance strategy and select a third-party group to run its MDEpiNet public-private partnership by the end of February.

FDA Unveils Plan To Strengthen Device Post-Market Surveillance

Combining new techniques with improvements to current tools, the strategy aims for "near real-time" post-market surveillance.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel